Skip to Content

Eurobio Scientific Bearer and/or Registered shares issued from reverse spli ALERS

Morningstar Rating
€14.28 −0.16 (1.11%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ALERS is trading at a 32% discount.
Price
€14.35
Fair Value
€32.47
Uncertainty
Very High
1-Star Price
€92.18
5-Star Price
€41.17
Economic Moat
Mnsx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ALERS is a good fit for your portfolio.

Trading Information

Previous Close Price
€14.44
Day Range
€14.2014.52
52-Week Range
€12.2018.10
Bid/Ask
€14.12 / €14.44
Market Cap
€145.80 Mil
Volume/Avg
1,639 / 5,387

Key Statistics

Price/Earnings (Normalized)
15.28
Price/Sales
1.14
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
1.21%

Company Profile

Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
304

Comparables

Valuation

Metric
ALERS
ALFRE
ARTO
Price/Earnings (Normalized)
15.281.8359.21
Price/Book Value
0.831.240.67
Price/Sales
1.140.228.39
Price/Cash Flow
7.338.84105.86
Price/Earnings
ALERS
ALFRE
ARTO

Financial Strength

Metric
ALERS
ALFRE
ARTO
Quick Ratio
2.261.207.02
Current Ratio
3.121.217.38
Interest Coverage
3.928.369.37
Quick Ratio
ALERS
ALFRE
ARTO

Profitability

Metric
ALERS
ALFRE
ARTO
Return on Assets (Normalized)
13.83%3.82%0.93%
Return on Equity (Normalized)
22.94%12.87%0.99%
Return on Invested Capital (Normalized)
16.62%8.02%0.47%
Return on Assets
ALERS
ALFRE
ARTO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesQydddhhrXmqwjh$185.4 Bil
SYK
Stryker CorpNhqlvrxpcXwgjc$127.7 Bil
BSX
Boston Scientific CorpKlpbmbfsrJgydvb$107.6 Bil
MDT
Medtronic PLCQvrkdzyghGmmmqql$105.9 Bil
DXCM
DexCom IncZtnsxhztnGrf$54.7 Bil
EW
Edwards Lifesciences CorpXzjkqnxfmTqzhyw$52.0 Bil
ZBH
Zimmer Biomet Holdings IncMmyltltsSvrn$24.6 Bil
ALGN
Align Technology IncVfsqbblVhcktp$23.4 Bil
PHG
Koninklijke Philips NV ADRKmcnmmfjzMcplsq$18.7 Bil
PODD
Insulet CorpDyxwfmvghWwsxzg$11.6 Bil

Sponsor Center